Ophthalmic topical use of collagen cross-linking inhibitors

Abstract

This invention relates to the treatment of wounded ocular tissue by the topical application of collagen cross-linking inhibitors to the tissue in order to reduce the cross-linking of collagen fibrils in the wounded tissue.